In this comprehensive presentation, Dr. Farah Hussain provides an in-depth look at Canada’s Drug Agency’s expanded role and innovative initiatives. Canada’s Drug Agency is transforming pharmaceutical reviews through innovative initiatives like the Target Zero Initiative, rolling reviews, and real-world evidence integration, while expanding its mandate to include improved system coordination, appropriate use strategies, and implementing key aspects of the PharmaCare Act.
Learn about the agency’s commitment to:
– Improving patient outcomes
– Increasing healthcare system efficiency
– Bringing transparency to drug reviews
Want More In-Depth Market Access Insights? Visit our comprehensive content hub: https://www.marketaccesscanada.ca/
